Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Direxion Daily Healthcare Bull 3X (CURE)

Direxion Daily Healthcare Bull 3X (CURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
5 Leveraged ETFs With Double-Digit Gains Halfway Through Q1

Amid the tariff trade war fears, economic slowdown concerns and roaring inflation, Wall Street has been on a bull run halfway through the first quarter. The S&P 500 touched record highs on several occasions,...

EDC : 55.98 (+10.85%)
CURE : 91.57 (+5.69%)
GDXU : 201.39 (+21.36%)
CWEB : 26.77 (+5.19%)
UTSL : 48.65 (-0.75%)
5 Leveraged ETFs That Witnessed Double-Digit Gains in January

Amid several twists and turns, the three major indices logged gains in January, with the Dow up 4.7%, the S&P 500 up 2.7% and the Nasdaq up 1.6%. This led to a spike in leveraged ETFs as investors looked...

WEBL : 16.82 (+10.51%)
DFEN : 63.10 (+11.19%)
FAS : 118.50 (+6.35%)
CURE : 91.57 (+5.69%)
GDXU : 201.39 (+21.36%)
5 Leveraged ETFs With Double-Digit Gains in August

The month of August was volatile for the U.S. stock market. After witnessing a steep sell-off at the start of the month, the major bourses recovered strongly, with the Dow Jones touching a series of new...

DFEN : 63.10 (+11.19%)
SHNY : 13.88 (+11.13%)
FAS : 118.50 (+6.35%)
CURE : 91.57 (+5.69%)
UTSL : 48.65 (-0.75%)

Barchart Exclusives

This Dividend King Is Down 26%. When Will It Bounce Back?
Abbott Laboratories is down 26% from its 52-week high due to a soft quarter. With 54 consecutive years of dividend hikes and guidance calling for mid-single-digit organic sales growth plus 10% EPS expansion, the Dividend King seems discounted, but the question is, can it rebound? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.